West, N., Hemmings, G., Richman, S., Taylor, M., Chambers, P., Magill, L., . . . Quirke, P. (2012). KRAS and BRAF Mutational Status can be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT trial.
Чикаго стиль цитування (17-те видання)West, N., et al. KRAS and BRAF Mutational Status Can Be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT Trial. 2012.
Стиль цитування MLA (9-ме видання)West, N., et al. KRAS and BRAF Mutational Status Can Be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT Trial. 2012.